Sequence Listing
For patent attorneys and their team, creating sequence listings can be a time-consuming and tedious task.
Our team of skilled, knowledgeable, and trained specialists can create high-quality sequence listings while also saving practitioners money and time. We use cutting-edge technology, algorithms we make ourselves, and our own experience to give our clients work that is free of mistakes and meets their needs.
Why is a sequence listing needed?
Separate sequence listing documents are required
It is necessary to submit separate sequence listing documents to represent the disclosed sequences when submitting a patent application for inventions in which specific sequences are disclosed in the patent specifications.
Which sequences must be listed
For every DNA sequence with ten (10) or more nucleotides and/or any amino acid sequence with four (4) or more specified amino acids, patent offices require the applicants to submit sequence listings in a standard format (WIPO Standard ST26, WIPO Standard ST25, US 37 C.F.R. 1.821–1.825).
Who requires a sequence listing?
IP lawyers (in corporations or law firms) who are writing the patents for DNA and peptide sequences.
Why Synoptic IP?
Life sciences specialists who know PTO compliance
We have a team of professionals with knowledge of PTO compliance who have graduate degrees in biotechnology and the life sciences and are experienced with WIPO, USA, and other jurisdictional norms.
Listings that adhere to ST26 and ST25
Our skilled professionals can create listings that adhere to PTO standards like ST26 and ST25.
We gather everything the PTO needs
The Synoptic team meets with the client and provides any extra information needed to prepare the sequence listing as specified by the PTO.
In-house algorithms plus industry tools
Combining in-house algorithms with tools for preparing sequence listings, such as WIPO Sequence Suite, PatentIn 3.5, and BiSSAP software, to maximise our efforts and generate results that are specific to the client.
Fast turnaround at fair prices
We provide speedy turnaround times and fair prices.
Sequence listing benefits
Sequences carry real legal weight
Genetic sequences are regarded legally and practically in a patent document as either chemical molecules or as elements that encode information. Their structure and function are quite significant in determining patent eligibility or infringement.
One listing accepted everywhere
An applicant can create a single listing through the use of a sequence listing that will be accepted by all receiving offices, preliminary examining authorities, and international searching authorities, as well as all selected and chosen national phase offices and international phase offices.
Words From Our Clients
Verified LinkedIn reviews and client correspondence from patent attorneys and in-house IP teams who come back to us project after project.
I used Synoptic for a validity search and was pleased with the results. The rates were highly competitive, the deliverable was on time, and the results were as good as (if not better than) other searches I’ve used.
Erin J. FoxIntellectual Property Counsel · ITW
Ankit did a very thorough and professional job on a claim chart assignment for us. He showed great perseverance when things got difficult and was able to get the job done. I would work with him again.
Eric BrownUS Patent Agent
Thank you — the search was quite helpful. We’ll have your invoice processed promptly.
Thank you for your work on this matter. We were pleased with the search and will consider you for future searches.
Looking for a First-Class Patent Search Consultant?
Get Quotes Now!Sequence Listing
For patent attorneys and their team, creating sequence listings can be a time-consuming and tedious task. Our team of skilled, knowledgeable, and trained specialists can create high-quality sequence listings while also saving practitioners money and time. We use cutting-edge technology, algorithms we make ourselves, and our own experience to give our clients work that is free of mistakes and meets their needs.
Why is a sequence listing needed?
It is necessary to submit separate sequence listing documents to represent the disclosed sequences when submitting a patent application for inventions that contain specific sequences are disclosed in the patent specifications.
For every DNA sequence with ten (10) or more nucleotides and/or any amino acid sequence with four (4) or more specified amino acids, patent offices require the applicants to submit sequence listings in a standard format (WIPO Standard ST26, WIPO Standard ST25, US 37 C.F.R. 1.821–1.825).
Why Synoptic IP?
- We have a Team of professionals with knowledge of PTO compliance who have graduate degrees in biotechnology and the life sciences and are experienced with WIPO, USA, and other jurisdictional norms.
- Our skilled professionals can create listings that adhere to PTO standards like ST26 and ST25.
- The synoptic team meets with the client and provides any extra information needed to prepare the sequence listing as specified by PTO.
- Combining in-house algorithms with tools for preparing sequence listings, such as WIPO Sequence Suite, PatentIn 3.5, and BiSSAP software, to maximise our efforts and generate results that are specific to the client.
- We provide speedy turnaround times and fair prices.
Who requires a sequence listing?
IP lawyers (in corporations or law firms) are writing the patents for DNA and peptide sequences.
Sequence listing benefits:
- Genetic sequences are regarded legally and practically in a patent document as either chemical molecules or as elements that encode information. Their structure and function are quite significant in determining patent eligibility or infringement.
- An applicant can create a single listing through the use of a sequence listing that will be accepted by all receiving offices, preliminary examining authorities, and international searching authorities, as well as all selected and chosen national phase offices and international phase offices.
Read More on Our Blogs
Explore more on our blogs to have a better understanding of our services.
India’s technology decade, read from the filing data
A docking manoeuvre, a stranded tunnel boring machine and six straight years of double-digit patent growth. What India actually built, where it genuinely stands, and what changes for anyone managing a patent portfolio.
Read Full Article
The Next Wave of Neuromodulation
Neuromodulation used to be a quiet corner of medtech — a handful of chronic-pain and movement-disorder devices, slow-moving and predictable. That is no longer true, and the patent landscape shows exactly where the next generation of advantage is being built.
Read Full Article
A Guide to Markush Structure Patent Search and Analysis
Imagine a picture representing not just a single molecule, but an entire family of related compound markush structure search. This is the essence of the Markush structure. It uses variables and wildcards to include a diverse set of molecules that share a common core structure.
Read Full Article